Wealth Alliance Advisory Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,242
Closed -$201K 162
2022
Q2
$201K Sell
2,242
-48
-2% -$4.86K 0.1% 133
2022
Q1
$254K Hold
2,290
0.11% 123
2021
Q4
$237K Buy
2,290
+71
+3% +$8.22K 0.1% 137
2021
Q3
$278K Buy
2,219
+10
+0.5% +$1.29K 0.14% 115
2021
Q2
$274K Sell
2,209
-37
-2% -$4.65K 0.13% 114
2021
Q1
$265K Hold
2,246
0.14% 116
2020
Q4
$263K Sell
2,246
-30
-1% -$3.3K 0.14% 116
2020
Q3
$237K Buy
2,276
+37
+2% +$3.72K 0.14% 106
2020
Q2
$205K Buy
+2,239
New +$215K 0.13% 113
2020
Q1
Sell
-2,139
Closed -$243K 129
2019
Q4
$243K Buy
2,139
+200
+10% +$21.9K 0.14% 112
2019
Q3
$209K Buy
+1,939
New +$202K 0.13% 115
2018
Q4
Sell
-2,220
Closed -$218K 134
2018
Q3
$218K Buy
+2,220
New +$205K 0.11% 122

Other funds holding MDT

Wealth Alliance Advisory Group's MDT Position: Q3 2022 in Review

Wealth Alliance Advisory Group sold out of Medtronic (MDT) in Q3 2022, closing a stake of 2,242 shares — an estimated $201K sold.

Wealth Alliance Advisory Group first reported a position in MDT in Q3 2018 and held it in 12 quarters. The position peaked at $278K in Q3 2021. 1,931 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

  • Wealth Alliance Advisory Group reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
  • Wealth Alliance Advisory Group sold 2,242 Medtronic shares in Q3 2022, an estimated $201K.
  • Wealth Alliance Advisory Group first reported a position in Medtronic in Q3 2018 and held it in 12 quarters.
  • Wealth Alliance Advisory Group's Medtronic position peaked at $278K in Q3 2021.
  • 1,931 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Wealth Alliance Advisory Group's 13F filing for Q3 2022, filed 12 Oct 2022.